Department of Medicine, Stanford Hospital and Clinics, Stanford, California, USA.
Department of Gastroenterology and Hepatology, Stanford Hospital and Clinics, Stanford, California, USA.
Gastrointest Endosc. 2019 Apr;89(4):842-851.e1. doi: 10.1016/j.gie.2018.08.029. Epub 2018 Aug 24.
Pancreatic intraepithelial neoplasia is associated with chronic pancreatitis (CP) changes on EUS. The objective of this study was to determine whether CP changes were more common in high-risk individuals (HRIs) than in control subjects and whether these changes differed among higher-risk subsets of HRIs.
HRIs and control subjects were identified from an endoscopy database. HRIs were defined as having predisposing mutations or a family history (FH) of pancreatic ductal adenocarcinoma. HRIs were classified as vHRIs who met Cancer of the Pancreas Screening (CAPS) criteria for high risk and mHRIs who did not. Multivariable logistic regression was used to adjust for confounders and CP risk factors.
Sixty-five HRIs (44 vHRIs, 21 mHRIs) and 118 control subjects were included. HRIs were included for FH (25), Lynch syndrome (5), Peutz-Jeghers syndrome (2), and mutations in BRCA1/2 (26), PALB2 (3), ATM (3), and CDKN2A (1). After adjustment for relevant variables, HRIs were 16 times more likely to exhibit 3 or more CP changes than control subjects (95% confidence interval, 2.6-97.0; P = .003). HRIs were also more likely to have hypoechoic foci (odds ratio, 8.0; 95% confidence interval, 1.9-32.9; P = .004). vHRIs and mHRIs did not differ in frequency of 3 or more CP changes on EUS.
HRIs were more likely to exhibit CP changes and hypoechoic foci on EUS compared with control subjects. HRIs with these findings may require closer surveillance. HRIs who did or did not meet CAPS criteria did not differ with regard to CP findings, supporting a more inclusive approach to screening.
超声内镜(EUS)下胰腺上皮内瘤变与慢性胰腺炎(CP)改变有关。本研究旨在确定高危个体(HRI)中CP 改变是否比对照组更常见,以及这些改变在 HRI 的更高危亚组中是否不同。
从内镜数据库中识别 HRI 和对照受试者。HRI 定义为具有易患突变或家族史(FH)的胰腺导管腺癌。HRI 分为符合癌症筛查(CAPS)高危标准的 vHRI 和不符合标准的 mHRI。多变量逻辑回归用于调整混杂因素和 CP 危险因素。
共纳入 65 名 HRI(44 名 vHRI,21 名 mHRI)和 118 名对照受试者。纳入 HRI 的原因包括 FH(25 例)、林奇综合征(5 例)、Peutz-Jeghers 综合征(2 例)、BRCA1/2(26 例)、PALB2(3 例)、ATM(3 例)和 CDKN2A(1 例)突变。在调整相关变量后,HRI 出现 3 种或更多 CP 改变的可能性是对照组的 16 倍(95%置信区间,2.6-97.0;P =.003)。HRI 也更有可能出现低回声灶(比值比,8.0;95%置信区间,1.9-32.9;P =.004)。EUS 上 vHRI 和 mHRI 出现 3 种或更多 CP 改变的频率无差异。
与对照组相比,HRI 更有可能在 EUS 上出现 CP 改变和低回声灶。具有这些发现的 HRI 可能需要更密切的监测。符合或不符合 CAPS 标准的 HRI 在 CP 发现方面没有差异,支持更具包容性的筛查方法。